MRKR Archived Articles
Marker Therapeutics (MRKR): A Promising Immuno-Oncology Innovator Advancing Next-Gen T Cell Therapies
Published on March 11, 2025
Marker Therapeutics, Inc. (MRKR): Navigating the Complexities of Immuno-Oncology
Published on September 24, 2024